Research and Markets: 2013 Report on the International Injectable Drug Delivery Market - Includes Forecasts to 2017

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/jqn5rx/injectable_drug) has announced the addition of the "2013 Report on the International Injectable Drug Delivery Market - Includes Forecasts to 2017" report to their offering.

The injectable drug delivery market is technology driven and is marked by the 'Threat of Obsolescence' wherein technologies as well as its adoption by patients changes very rapidly. The industry has seen a shift in paradigm and is now skewed toward self-injection devices that not only cure serious illnesses but also have fewer serious side effects.

The market for injectable drug delivery includes devices and formulations. Traditionally, injectable devices were primarily designed for delivery of insulin and human growth hormones. However, due to technological advancements they are currently being used as combination therapies for the delivery of a wide variety of drug classes such as anticholinergic, hematopoietic, dopamine agonists, parathyroid hormones, reproductive hormones, serotonin antagonists, sympathomimetic and immune modulators.

Self injection devices including auto injectors and pen injectors are the fastest growing segments in the injectable drug delivery market. In recent years, the uptake and adoption of self-injection devices such as auto and pen injectors has grown substantially. This is due to the benefits it offers over conventional injection devices. Self-injection devices ensure better patient adherence to treatment due to decrease risk of missed injection or drug discontinuation, and reduced healthcare cost as costly hospital visits are curtailed. This has ignited the interest of device manufacturers who are in turn incessantly coming up with new variants of self-injection devices with advanced technological features.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Global Injectable Drug Delivery Devices Technologies Market

5 Global Injectable Drug Delivery Formulation Technologies Market

6 Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications

7 Geographic Analysis

8 Competitive Landscape

9 Company Profiles

Companies Mentioned:

  • Alkermes
  • Antares Pharma
  • Baxter International
  • Becton, Dickinson And Company
  • Bespak Europe
  • Crossject
  • Elcam Medical
  • Eli Lilly And Company
  • Gerresheimer
  • Haselmeier
  • Injex Pharma
  • Novo Nordisk
  • Owen Mumford
  • Sanofi
  • Schott
  • Shl Group
  • Terumo Corporation
  • Unilife Corporation
  • Vetter Pharma-Fertigung
  • West Pharmaceutical Services
  • Ypsomed Holding
  • Zogenix

For more information visit http://www.researchandmarkets.com/research/jqn5rx/injectable_drug

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery